Please assess the completion status of the following clinical trial:

Trial Title: Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject is 7 to 80 years of age.~2. Has asthma~3. Has been identified as a candidate for inhaled corticosteroid (ICS) treatment~4. Is willing and able to perform Vivatmo pro™ testing~Exclusion Criteria:~1. Subject has used corticosteroids prior to enrollment.~2. Subject has other current serious medical conditions~3. Subject has not been clinically stable for at least 2 weeks prior to the study~4. Subject is unwilling or unable to perform Vivatmo pro testing

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Test Cohort (Type: EXPERIMENTAL): Subjects age 7 to 80 with asthma

Based on this trial design, predict the completion outcome and termination type (if applicable).